Expertise is crucial to prolong survival in average risk medulloblastoma: long-term results of a retrospective study.

Enrico FranceschiSantino MinichilloAlicia TosoniMaurizio MascarinAntonella MuraMonica Di BattistaVincenzo Di NunnoLidia GattoRaffaele LodiStefania BartoliniAlba Ariela Brandes

Published in: Tumori (2021)

Treating patients with average-risk medulloblastoma in a referral center improves both PFS and OS, does adding adjuvant chemotherapy.

Keyphrases

primary care